Mevlit Íkbal
- Co-authors
- İbrahım PirimMustafa AtasoyCihangir AliağaoğluAyhan TaştekınAlper Han ÇebiRahmi ÖrsAkçahan GepdíremenGüleray Ağar
- Topics
- Carcinogens and Genotoxicity Assessment (4 papers)Systemic Lupus Erythematosus Research (3 papers)Ocular Diseases and Behçet’s Syndrome (3 papers)
- Journals
- Annals of the Rheumatic DiseasesPharmacological ResearchMutation research. Fundamental and molecular mechanisms of mutagenesis
- Partner nations
- TürkiyeUnited KingdomNorway
In The Last Decade
Mevlit Íkbal
25 papers receiving 239 citations
Peers
Comparison fields: 5 of 81
- Rheumatology 64
- Ophthalmology 54
- Molecular Biology 48
- Cancer Research 28
- Immunology 28
Countries citing papers authored by Mevlit Íkbal
This map shows the geographic impact of Mevlit Íkbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mevlit Íkbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mevlit Íkbal more than expected).
Fields of papers citing papers by Mevlit Íkbal
This network shows the impact of papers produced by Mevlit Íkbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mevlit Íkbal. The network helps show where Mevlit Íkbal may publish in the future.
Co-authorship network of co-authors of Mevlit Íkbal
This figure shows the co-authorship network connecting the top 25 collaborators of Mevlit Íkbal. A scholar is included among the top collaborators of Mevlit Íkbal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mevlit Íkbal. Mevlit Íkbal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | 2 | |
| 6 | 16 | |
| 7 | IL-10 AND IL-17 GENE POLYMORPHISMS IN ADULT IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 |
| 8 | 10 | |
| 9 | 14 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 4 | |
| 13 | Genotoxic Evaluation of the Antibacterial Drug, Ciprofloxacin, in Cultured Lymphocytes of Patients with Urinary Tract Infection | 6 |
| 14 | 26 | |
| 15 | 54 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 13 | |
| 19 | 11 | |
| 20 | 11 |
About Mevlit Íkbal
Mevlit Íkbal is a scholar working on Cancer Research, Rheumatology and Ophthalmology, having authored 25 papers that have together received 247 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). The work is most often cited by research in Ophthalmology (54 citations), Rheumatology (64 citations) and Chemical Health and Safety (2 citations). Mevlit Íkbal has collaborated with scholars based in Türkiye, United Kingdom and Norway. Frequent co-authors include İbrahım Pirim, Mustafa Atasoy, Cihangir Aliağaoğlu, Ayhan Taştekın, Alper Han Çebi, Rahmi Örs, Akçahan Gepdíremen, Güleray Ağar, Lokman Alpsoy and Teoman Erdem. Their work appears in journals such as Annals of the Rheumatic Diseases, Pharmacological Research and Mutation research. Fundamental and molecular mechanisms of mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.